Pregabacon 150 mg (Pregabalin)

Adult dose

This medication should be taken orally, divided into two doses daily without regard to meals. Neuropathic Pain (Peripheral and Central): As a starting dose, administer 150 mg once daily and may increase to 300 mg once daily based on patient response and tolerance, after 3 to 7 days. Further increases up to a maximum of 600 mg once daily can be made every 7 days. Epilepsy: Starting dose of 150 mg once daily.

Child dose

There is insufficient safety and efficacy data for pediatric patients under 12 years of age and adolescents aged 12 to 17 years, so administration is not recommended.

This medication may increase the risk of suicidal thoughts or behavior, and patients should be closely monitored for symptoms of depression or mood changes during use. Patients with hypersensitivity to this drug or specific inherited lactose intolerance disorders should not take this medication. For diabetic patients, dose adjustments for blood sugar control medications may be necessary due to potential weight gain. If signs of allergic reactions such as angioedema occur, this medication should be discontinued immediately. Elderly patients should take special care when starting this medication to avoid risks of falls due to dizziness or drowsiness. Any occurrence of blurred vision or visual changes should be discussed with a healthcare provider. Abrupt discontinuation of this medication may result in withdrawal symptoms such as insomnia, headache, and anxiety, so it should be tapered off gradually under the guidance of a healthcare provider. Patients with a history of substance abuse may have a higher risk of abuse with this medication and should be closely monitored. Patients with impaired kidney function may require dose adjustments. Patients with cardiovascular disease must be carefully monitored during administration of this drug. When combined with opioid analgesics, the risk of central nervous system depression is increased, so caution is necessary. This medication may cause dizziness and drowsiness, so patients should check their condition before driving or operating dangerous machinery. In the early stages of pregnancy, there is a risk of congenital malformations in the fetus, so pregnant women should avoid taking this medication, and women of childbearing age should use effective contraception. Breastfeeding women should discuss with their healthcare provider as this medication may be transferred to breast milk. Overdose may cause symptoms such as confusion, drowsiness, and depression, and may require treatment such as dialysis if necessary. Keep this medication out of the reach of children and avoid transferring it to other containers.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in mucous membranes of mouth/eyes, difficulty breathing or shortness of breath, asthma attacks, breathing variations accompanied by cough and fever, jaundice (yellowing of skin or eyes), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion of consciousness, vision abnormalities, paralysis, urination issues

Mild side effects

• Dizziness
• drowsiness
• confusion
• impaired coordination
• irritability
• depression
• euphoria
• decreased libido
• insomnia
• depersonalization

This medication should be stored in a tightly sealed container to keep it protected from air and moisture, and it is best kept at room temperature between 15 to 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness.

Appearance

White hard gelatin capsule containing white powder

Package unit

30 capsules per bottle, 60 capsules per bottle